GFI1 enhances MHC-I expression in tumor cells and augments tumor responsiveness to PD-1/PD-L1 inhibitors
- DOI
- 10.1007/s00262-026-04430-y
- Published
- 2026-05-22
- Container
- Cancer Immunology, Immunotherapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00262-026-04430-y,
title = {GFI1 enhances MHC-I expression in tumor cells and augments tumor responsiveness to PD-1/PD-L1 inhibitors},
author = {Yu Xi and Kewei Xiao and Kelin Meng and Taiyan Yu and Tianlai Wang and Xu Wang and Ounan Pan and Chenxi Zeng and Xue Wang and Xiangning Fu and Lequn Li},
year = {2026},
journal = {Cancer Immunology, Immunotherapy},
doi = {10.1007/s00262-026-04430-y},
url = {https://doi.org/10.1007/s00262-026-04430-y}
}RIS
TY - JOUR TI - GFI1 enhances MHC-I expression in tumor cells and augments tumor responsiveness to PD-1/PD-L1 inhibitors AU - Yu Xi AU - Kewei Xiao AU - Kelin Meng AU - Taiyan Yu AU - Tianlai Wang AU - Xu Wang AU - Ounan Pan AU - Chenxi Zeng AU - Xue Wang AU - Xiangning Fu AU - Lequn Li PY - 2026 JO - Cancer Immunology, Immunotherapy DO - 10.1007/s00262-026-04430-y UR - https://doi.org/10.1007/s00262-026-04430-y ER -
APA
Xi, Y., Xiao, K., Meng, K., Yu, T., Wang, T., Wang, X., Pan, O., Zeng, C., Wang, X., Fu, X., & Li, L. (2026). GFI1 enhances MHC-I expression in tumor cells and augments tumor responsiveness to PD-1/PD-L1 inhibitors. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04430-y
Source records
- crossref · retrieved 2026-11-10T19:10:53.392Z